Showing results (171-180 of 344) with videos related to

Sort By:
Pageof 35
Human Vaccines & Immunotherapeutics|November 27, 2014
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine when administered to healthy Japanese adults aged ≥50 years. An open-label trialMasanari Shiramoto, Shin Irie, Christine Juergens, et al.
The Pediatric Infectious Disease Journal|October 19, 2019
Immunogenicity and Safety of the 13-Valent Pneumococcal Conjugate Vaccine Administered in a 3 + 1 versus 2 + 1 Dose Schedule Among Infants in ChinaFengcai Zhu, Yuemei Hu, Jingxin Li, et al.
The Pediatric Infectious Disease Journal|September 25, 2012
The 13-valent pneumococcal conjugate vaccine for invasive pneumococcal disease in Alaska native children: results of a clinical trialRosalyn Singleton, Jay Wenger, Joseph A Klejka, et al.
Nature Communications|June 10, 2021
Structural basis for inhibition of the AAA-ATPase Drg1 by diazaborineMichael Prattes, Irina Grishkovskaya, Victor-Valentin Hodirnau, et al.
Clinical Hemorheology and Microcirculation|September 29, 2019
Growth-related micromorphological characteristics of the porcine femoral arteryA Nies, L Proft, M E Nehring, et al.
Nucleic Acids Research|December 11, 1999
MIPS: a database for genomes and protein sequencesH W Mewes, D Frishman, C Gruber, et al.
Pageof 35